James Aloysius Brady Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

James Aloysius Brady is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 100,000 shares of XERS, which is worth approximately $468,000. The most recent transaction as insider was on Mar 28, 2025, when has been sold 100,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K

0% 3M change

n/a 12M change

Total Value Held $468,000

James Aloysius Brady Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 28 2025	BUY Grant, award, or other acquisition	-	100,000 Added 50.0%	100,000 Common Stock

Also insider at

VRNA

Verona Pharma plc Healthcare

Director

JAB